Another study determined that APOA1 levels were significantly elevated in SCLC, despite not being markedly increased in non-small-cell lung cancer (NSCLC), and found that reduced APOA1 levels correlated with an increased recurrence of SCLC [100]. Here, APOA1 is linked to non-small cell lung carcinoma.